Heart Valve Disease Clinical Trials

5 recruiting

Heart Valve Disease Trials at a Glance

31 actively recruiting trials for heart valve disease are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Ann Arbor, New York, and Chicago. Lead sponsors running heart valve disease studies include Assistance Publique - Hôpitaux de Paris, TRiCares, and China National Center for Cardiovascular Diseases.

Browse heart valve disease trials by phase

Treatments under study

About Heart Valve Disease Clinical Trials

Looking for clinical trials for Heart Valve Disease? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Valve Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Valve Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Not Applicable

The TRICURE EU Pivotal Study

Cardiovascular DiseasesHeart Valve DiseaseTricuspid Valve Regurgitation
TRiCares80 enrolled8 locationsNCT06581471
Recruiting
Not Applicable

The TRICURE EFS Study

Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
TRiCares15 enrolled9 locationsNCT06506942
Recruiting
Not Applicable

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Heart FailureCardiovascular DiseasesHeart Diseases+3 more
Cardiac Dimensions, Inc.300 enrolled92 locationsNCT03142152
Recruiting

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

Heart Valve DiseasesLeft Ventricular Dysfunction
Queen Mary University of London500 enrolled1 locationNCT05208567
Recruiting

GLS in Difficult CPB Weaning

Heart Valve DiseasesCoronary Artery BypassEchocardiography+3 more
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital213 enrolled2 locationsNCT07390903
Recruiting

Transpacific TAVR Registry

Heart Valve DiseasesAortic Valve Insufficiency
Duk-Woo Park, MD10,000 enrolled7 locationsNCT03826264
Recruiting
Not Applicable

Echocardiography in Nursing Home

Heart FailureHeart DiseasesHeart Valve Diseases
Nantes University Hospital1,050 enrolled1 locationNCT06445231
Recruiting

Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery

Myocardial IschemiaHeart Valve DiseasesAortic Diseases+3 more
Muhammet Talha Ceran, MD80 enrolled1 locationNCT07249424
Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Aortic Valve DiseaseHeart Valve DiseaseTricuspid Valve Regurgitation+11 more
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled15 locationsNCT07267117
Recruiting
Not Applicable

EFS of the DUO System for Tricuspid Regurgitation

Tricuspid RegurgitationHeart Valve DiseasesTricuspid Valve Insufficiency+1 more
CroiValve Limited15 enrolled16 locationsNCT05913908
Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Heart Valve DiseaseTAVIM-TEER+5 more
Montreal Heart Institute21,000 enrolled15 locationsNCT07213531
Recruiting
Not Applicable

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Heart TransplantMyocardial InfarctionCoronary Artery Disease+3 more
University of California, San Francisco516 enrolled5 locationsNCT05933083
Recruiting
Phase 3

Antagonization of Heparin With Protamine Sulfate After TAVI

Heart Valve DiseasesAortic Valve Stenosis
Assistance Publique - Hôpitaux de Paris940 enrolled1 locationNCT06215378
Recruiting
Phase 4

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

Heart Valve DiseasesLeft Ventricle RemodelingAortic Regurgitation Disease
Vitor Emer Egypto Rosa60 enrolled1 locationNCT07099859
Recruiting
Not Applicable

CTSN Embolic Protection Trial

Acute Kidney InjuryCoronary Artery DiseaseDelirium+2 more
Icahn School of Medicine at Mount Sinai842 enrolled28 locationsNCT06027788
Recruiting

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
Edwards Lifesciences500 enrolled2 locationsNCT06569602
Recruiting
Phase 4

Calcium-Phosphorus Regulation Therapy on Heart Valve Disease

Chronic Kidney Disease(CKD)Degenerative Heart Valve DiseaseHeart Valve Calcification+1 more
China National Center for Cardiovascular Diseases196 enrolled1 locationNCT06660524
Recruiting

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

CardiomyopathiesBrain NeoplasmsHypertension+9 more
First Affiliated Hospital Xi'an Jiaotong University25,000 enrolled1 locationNCT06001073
Recruiting
Not Applicable

Cardiopulmonary Rehabilitation In Heart Valve Surgery

Heart Valve Diseases
Istanbul Saglik Bilimleri University60 enrolled1 locationNCT06493123
Recruiting

The Prospective LEUVEN Transcatheter Valve Therapy Registry

Heart Valve Diseases
Universitaire Ziekenhuizen KU Leuven5,000 enrolled1 locationNCT03674788